首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction.
【24h】

Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction.

机译:在由肾量减少引起的实验性肾纤维化大鼠中,内皮糖蛋白(一种TGF-β结合蛋白)上调。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The central process in chronic renal failure is the progressive accumulation of extracellular matrix in the glomeruli and in the tubulo-interstitial space, resulting in renal fibrosis. Transforming growth factor-beta1 (TGF-beta1) up-regulation plays a major role in the genesis of renal fibrosis. Endoglin is a membrane glycoprotein that binds TGF-beta1 and TGF-beta3 with high affinity. An increased level of endoglin immunostaining has been demonstrated previously in biopsies from patients with chronic progressive renal disease. We have assessed the expression of endoglin in the rat 5/6th renal mass reduction (RMR) model. METHODS: One, 3 and 5 months after RMR, mean arterial pressure and renal function were measured, animals were sacrificed, renal fibrosis was evaluated quantitatively and the expression of endoglin was assessed by western blot, northern blot and immunohistochemistry. RESULTS: RMR induced a progressive increase in mean arterial pressure and urinary protein excretion. Renal corpuscular area, and mesangial and interstitial fibrosis increased with time after RMR. Immunohistochemical staining for endoglin demonstrated its expression mainly on the endothelial surface of major vessels. In kidneys 1 and 3 months after RMR, the expression of endoglin in renal corpuscles was limited to Bowman's parietal epithelium. In rats 5 months after RMR, the immunoexpression in glomerular endothelium was more marked. Northern blot analysis revealed that rats with RMR showed an increase in the expression of mRNA for endoglin, only at 5 months after RMR. Western blot analysis gave a different time course: a marked increase in the first month, a decrease in the 3rd month and a further increase in the 5th month after RMR. CONCLUSIONS: The present study demonstrates increased endoglin expression in rats with severe hypertension and renal damage. This increased endoglin expression coincides with the period of higher renal damage and renal dysfunction.
机译:背景:慢性肾功能衰竭的主要过程是肾小球和肾小管间质间隙中细胞外基质的逐步积累,从而导致肾纤维化。转化生长因子-β1(TGF-β1)上调在肾纤维化的发生中起主要作用。内皮糖蛋白是一种膜糖蛋白,可以高亲和力结合TGF-beta1和TGF-beta3。先前已经在患有慢性进行性肾脏疾病的患者的活组织检查中证明了内皮糖蛋白免疫染色水平的提高。我们已经评估了内皮糖蛋白在大鼠第5/6号肾脏减重(RMR)模型中的表达。方法:在RMR后1、3和5个月,测量平均动脉压和肾功能,处死动物,定量评估肾纤维化,并通过western blot,northern blot和免疫组织化学评估内皮糖蛋白的表达。结果:RMR引起平均动脉压和尿蛋白排泄的逐渐增加。 RMR后,肾小体面积,肾小球膜和间质纤维化随时间增加。内皮糖蛋白的免疫组织化学染色显示其表达主要在主要血管的内皮表面上。在RMR后1和3个月的肾脏中,内皮糖蛋白在肾脏小体中的表达仅限于Bowman顶叶上皮细胞。在RMR后5个月的大鼠中,肾小球内皮细胞的免疫表达更为明显。 Northern印迹分析显示,具有RMR的大鼠仅在RMR后5个月才显示内皮糖蛋白的mRNA表达增加。 Western blot分析给出了不同的时间过程:RMR后第一个月显着增加,第三个月减少,第五个月进一步增加。结论:本研究证明严重高血压和肾损害的大鼠内皮糖蛋白表达增加。内皮糖蛋白表达的增加与较高的肾损害和肾功能不全时期相吻合。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号